학술논문
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
Document Type
article
Author
Lingzhi Hong; Muhammad Aminu; Shenduo Li; Xuetao Lu; Milena Petranovic; Maliazurina B. Saad; Pingjun Chen; Kang Qin; Susan Varghese; Waree Rinsurongkawong; Vadeerat Rinsurongkawong; Amy Spelman; Yasir Y. Elamin; Marcelo V. Negrao; Ferdinandos Skoulidis; Carl M. Gay; Tina Cascone; Saumil J. Gandhi; Steven H. Lin; Percy P. Lee; Brett W. Carter; Carol C. Wu; Mara B. Antonoff; Boris Sepesi; Jeff Lewis; Don L. Gibbons; Ara A. Vaporciyan; Xiuning Le; J. Jack Lee; Sinchita Roy-Chowdhuri; Mark J. Routbort; Justin F. Gainor; John V. Heymach; Yanyan Lou; Jia Wu; Jianjun Zhang; Natalie I. Vokes
Source
Nature Communications, Vol 14, Iss 1, Pp 1-15 (2023)
Subject
Language
English
ISSN
2041-1723
Abstract
Immune checkpoint inhibitors with or without chemotherapy are now standard of care for non-small cell lung cancer. However, the benefits of combination vs sequential therapy have not been fully explored. Here, the authors analysed 1,133 patient records and show combination therapy showed increased protection against early progression, but similar overall survival.